Eidogen-Sertanty licenses Target Informatics Platform to NCBI
San Diego, CA (March 9, 2006) – Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today that they have licensed their Target Informatics Platform™ (TIP™) to the U.S. National Library of Medicine’s National Center for Biotechnology Information (NCBI), based in Bethesda, MD.
Under the terms of the annual license, scientists at the NCBI will have access to the TIP structural knowledgebase as well as Eidogen-Sertanty’s EVE Comparative Visualizer.
“We’re extremely pleased to be collaborating with the NCBI. They have developed a number of outstanding and widely used informatics platforms over the years, and I’m optimistic that our interaction will lead to new high impact advances,” said Derek Debe, Eidogen-Sertanty’s Chief Scientific Officer.
About Eidogen-Sertanty, Inc.
Eidogen-Sertanty, formed in March 2005 from the merger of Eidogen and Sertanty, is a privately held company providing pioneering knowledge-driven discovery solutions to biotechnology and pharmaceutical organizations. Eidogen-Sertanty’s unique and powerful suite of software, databases, and drug discovery services enable customers and collaborators to apply a knowledge-driven discovery approach to a variety of workflows and processes, including target selection and prioritization, library building and compound prioritization, and lead design and optimization. To find out more about Eidogen-Sertanty and their products and services please visit www.eidogen-sertanty.com.
About NCBI
The National Center for Biotechnology Information is part of the National Library of Medicine. Established in 1988 as a national resource for molecular biology information, NCBI creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information-all for the better understanding of molecular processes affecting human health and disease. NCBI is host to the GenBank nucleotide sequence database.
# # #
Contact Information:
Steven Muskal
760-729-0211
pr@eidogen-sertanty.com
|
